ClinicalTrials.Veeva

Menu

Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic Cholecystectomy

C

Changi General Hospital

Status

Completed

Conditions

Cholecystitis
Choledocholithiasis

Treatments

Device: Laryngeal Mask Airway-Supreme
Device: Endotracheal Tube

Study type

Interventional

Funder types

Other

Identifiers

NCT02037958
CGHLMAS2010

Details and patient eligibility

About

We hypothesise that the use of the LMA-Supreme provides greater ease of insertion and reduced haemodynamic variability during insertion compared to the tracheal tube, whilst still maintaining a patent airway to facilitate elective laparoscopic cholecystectomy in selected patients.

Full description

The Laryngeal Mask Airway Supreme(LMA-S) has been used successfully to maintain a patent airway for laparoscopic surgery. Our study compares the use of LMA-S with that of the tracheal tube (ETT) with respect to the ease of insertion and potential haemodynamic disturbance during insertion.

Enrollment

76 patients

Sex

All

Ages

21 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) Physical Status 1 and 2
  • Undergoing elective laparoscopic cholecystectomy

Exclusion criteria

  • BMI > 30
  • Known gastro-oesophageal reflux disease
  • predicted or documented difficult airway
  • contraindications to drugs in the standardized anaesthesia protocol

Trial design

76 participants in 2 patient groups

Laryngeal Mask Airway-Supreme
Experimental group
Description:
Patients who are randomly assigned to receive the LMA-Supreme
Treatment:
Device: Laryngeal Mask Airway-Supreme
Endotracheal Tube
Active Comparator group
Description:
Patients who are randomly assigned to receive endotracheal intubation
Treatment:
Device: Endotracheal Tube

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems